AI brief
Auto-generated summary of filings, earnings, and institutional changes · not a buy/sell recommendation
AI-generatedConfidence 55%English
- 매출 ₩53.35억
- 순이익 QoQ -34.4%
- 최근 경영공시 10건 — 공시 빈도 주의
Cellromax Science Co., Ltd. (471820) 의 최근 흐름을 간단히 정리합니다. 실적 발표가 가까워졌습니다. 컨센서스 EP…
Available on Premium+
See the full AI brief
A one-paragraph summary of filings, earnings, 13F, and research actions + next checkpoints + sources.
This summary is generated automatically from public sources (SEC EDGAR, earnings releases, 13F, public research). It is not investment advice; buy/sell decisions are your own responsibility.